BioLineRx Ltd. (BLRX) stock
BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.12−0.03 (-2.61%)
Close on Nov 17, 2026Market cap $4.87MP/E –Yield –
BioLineRx price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
BioLineRx's price to sales ratio was 5.2× on Nov 11, 2026, against 0.2× a year earlier. Over the last 3 years it ranged from 0.2× to 15.0×, with a median of 5.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.2× | +5.0 |
| 2025 | Dec 31, 2025 | 0.2× | −2.7 |
| 2024 | Dec 31, 2024 | 2.9× | – |
See a number that looks wrong?